# Italy Thyroid Test Market > Italy Thyroid Test Market Research Report: Size, Share, Trend Analysis By Types (TSH Tests, T4 Tests, T3 Tests, Other) and By End Users (Hospital, Diagnostic Laboratories, Research Laboratories and Institutes) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.29% - **2024:** $ 79.45 Million - **2025:** $ 83.65 Million - **2035:** $ 140 Million - **Key Players:** Abbott Laboratories (US), Roche Diagnostics (CH), Siemens Healthineers (DE), Thermo Fisher Scientific (US), PerkinElmer (US), Bio-Rad Laboratories (US), Ortho Clinical Diagnostics (US), Quest Diagnostics (US) **Report ID:** MRFR/HC/49861-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** August 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/italy-thyroid-test-market-51619 --- ## Market Summary ## **Italy Thyroid Test Market Overview** As per MRFR analysis, the Italy Thyroid Test Market Size was estimated at 50.23 (USD Million) in 2023. The Italy Thyroid Test Market Industry is expected to grow from 53.1 (USD Million) in 2024 to 95 (USD Million) by 2035. The Italy Thyroid Test Market CAGR (growth rate) is expected to be around 5.431% during the forecast period (2025 - 2035). ### **Key Italy Thyroid Test Market Trends Highlighted** The Italy Thyroid Test Market is witnessing significant trends driven by the rising prevalence of thyroid disorders in the country. The increasing awareness of thyroid health and its implications on overall well-being plays a pivotal role in shaping the market dynamics. Citizens in Italy are becoming more informed about the symptoms and risks associated with thyroid conditions, leading to a higher demand for diagnostic tests. Moreover, government initiatives aimed at promoting preventive healthcare have bolstered screening efforts, resulting in more individuals seeking thyroid testing. Recent times have shown a shift towards personalized medicine, where tailored treatments are preferred based on individual patient profiles. The demand for more refined and specific thyroid testing methods, such as genetic testing and hormone profiling, is being influenced by this trend. The adoption of telemedicine, as well as the integration of technology into healthcare, is further improving the accessibility of thyroid tests, particularly in rural areas of Italy where healthcare resources may be scarce. Opportunities in the Italy Thyroid Test Market are present in the development of innovative and user-friendly testing solutions, such as at-home test devices that can promote self-screening. Furthermore, the establishment of integrated patient management platforms through collaboration between healthcare providers and technology companies can facilitate improved treatment and follow-up. The Italy Thyroid Test Market is well-positioned for growth and innovation in the near future due to the increasing consumer preference for preventive healthcare and the emphasis on early diagnosis. Personalised and patient-centered approaches will be essential in addressing the requirements of individuals affected by thyroid disorders in Italy as healthcare systems continue to develop. ##    Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Italy Thyroid Test Market Drivers** ### **Increasing Prevalence of Thyroid Disorders** Italy has recorded a significant uptick in diagnosed thyroid disorders over the past decade, particularly hypothyroidism and hyperthyroidism. Research indicates that the prevalence of thyroid conditions is approximately 10% of the population, creating a substantial need for diagnostic tests. The Italian Ministry of Health has reported that the number of diagnosed cases increased by approximately 20% from 2015 to 2020, leading to heightened demand for reliable thyroid testing. This surge is further supported by the Italian Society of Endocrinology, which emphasizes regular screening for at-risk populations, thereby propelling growth in the Italy Thyroid Test Market Industry. With an aging demographic that often experiences thyroid dysfunction, the potential market for testing and monitoring remains robust and pivotal for future growth. ### **Rising Awareness and Education on Thyroid Health** There is an increasing public and medical awareness regarding the importance of thyroid health, which is significantly driving the Italian Thyroid Test Market. Campaigns initiated by notable organizations such as the Italian Thyroid Association aim to educate the community about the implications of thyroid diseases and the necessity for screening. Over the last five years, the campaigns have reportedly reached over 3 million individuals across Italy, encouraging more people to seek testing. This awareness leads to earlier diagnosis and treatment, thus promoting an increase in the frequency of thyroid tests. ### **Advancements in Thyroid Testing Technology** Technological advancements in the field of diagnostic testing have enabled more accurate and faster results for thyroid tests. The introduction of point-of-care testing devices and innovative lab equipment has improved the accessibility and efficiency of thyroid diagnostics. In Italy, leading companies and hospital networks have begun integrating these technologies into their service offerings, thus enhancing patient outcomes. For instance, advances in biomarkers for thyroid function have reduced testing times by up to 30%, positively impacting patient flow within healthcare facilities. This efficiency translates into higher testing rates, thereby benefiting the Italy Thyroid Test Market Industry. ## **Italy Thyroid Test Market Segment Insights** ### **Thyroid Test Market Type Insights** The Italy Thyroid Test Market, particularly concerning the Type segment, presents a well-structured landscape that is essential for understanding thyroid function assessment in the region. The market is divided into various testing categories such as TSH Tests, T4 Tests, T3 Tests, and other specialized tests. TSH Tests, which measure Thyroid Stimulating Hormone, are integral as they provide initial insights into thyroid abnormalities, and their demand continues to rise owing to a growing prevalence of thyroid disorders in Italy, influenced by factors like dietary habits and environmental conditions. T4 Tests are critical for diagnosing and monitoring patients with hypothyroidism and hyperthyroidism; their significance is underscored by increased awareness about thyroid health among the Italian population and advancements in diagnostic tools. T3 Tests, though less commonly ordered, are crucial for assessment in specific clinical scenarios such as suspected thyroid hormone resistance, contributing to a more nuanced understanding of thyroid function in patients presenting with complex symptoms. Furthermore, the testing category 'Other' encompasses various assessments that may include thyroid antibodies and additional hormones, catering to patients with unique thyroid conditions or those tracking treatment efficacy. This segment offers doctors a complete view of thyroid health, which contributes to more personalized and effective management strategies. Collectively, these components of the Type segment reflect a robust framework within the Italy Thyroid Test Market, characterized by continuous growth driven by technological advancements, increasing screening programs, and a proactive approach to health awareness among the Italian populace. The trends indicate an ongoing shift toward more comprehensive testing options, emphasizing the crucial role these various testing types play in ensuring early detection and improved patient outcomes in thyroid-related health issues throughout Italy. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Thyroid Test Market End User Insights** The End User segment of the Italy [Thyroid Test Market](../../../reports/thyroid-test-market-8548) plays a crucial role in the healthcare ecosystem, comprising primary venues such as Hospitals, Diagnostic Laboratories, and Research Laboratories and Institutes. Hospitals serve as the predominant End User, equipped with advanced technologies and a higher patient inflow, thereby facilitating a large volume of thyroid tests. Diagnostic Laboratories, on the other hand, are pivotal for their specialized diagnostic capabilities, providing rapid and accurate results that are essential for timely treatment and disease management. Research Laboratories and Institutes contribute by advancing innovations in thyroid health, focusing on the development of new and improved diagnostic methods. As thyroid disorders are prevalent in Italy, driven by both genetic and environmental factors, the demand for reliable testing methods remains significant. The collaboration between these End Users reflects growing awareness of thyroid health among the population, further amplified by initiatives aimed at addressing healthcare accessibility and improving diagnostic precision. Overall, this segment’s dynamic interplay highlights its importance in enhancing healthcare outcomes and driving market growth within the Italy Thyroid Test Market. ## **Italy Thyroid Test Market Key Players and Competitive Insights** The Italy Thyroid Test Market is characterized by a growing focus on advanced diagnostic solutions and the increasing prevalence of thyroid disorders among the population. This environment has spurred significant competition as companies strive to innovate and enhance their product offerings to meet the needs of healthcare professionals and patients alike. Key players in the market are investing in research and development to improve the accuracy, speed, and convenience of thyroid testing. This competitive landscape is shaped by a variety of factors, including technological advancements, regulatory frameworks, and the rise of personalized medicine, which has heightened the demand for reliable and efficient diagnostic tests. Competitors are also emphasizing strategic partnerships, collaborations, and geographical expansion to solidify their market positions and increase their reach within the growing Italian healthcare sector. Thermo Fisher Scientific is a prominent player in the Italy Thyroid Test Market, leveraging its strong reputation for quality and innovation. The company's robust portfolio includes a range of diagnostic products specifically designed for thyroid function tests, which are crucial for accurate diagnosis and management of thyroid disorders. Its strengths lie in advanced technology, which ensures high sensitivity and specificity in test results. Moreover, Thermo Fisher Scientific benefits from a well-established distribution network across Italy, allowing for effective market penetration and accessibility for healthcare providers. The company’s commitment to continuous improvement and adaptation to emerging trends in the healthcare sector further enhances its competitive edge, enabling it to maintain strong relationships with clinicians and laboratories that rely on its testing solutions. Labcorp is another significant entity within the Italy Thyroid Test Market, known for its comprehensive range of laboratory services including thyroid testing. The company focuses on providing timely and accurate diagnostic solutions that cater to the needs of healthcare practitioners. Key products and services include a variety of assays that measure different thyroid hormones, aiding in the diagnosis and monitoring of thyroid-related conditions. Labcorp's extensive presence in Italy is bolstered by strategic mergers and acquisitions, which have broadened its geographical footprint and enhanced its service delivery capabilities. The company's strengths include its advanced testing methodologies, a commitment to quality assurance, and a strong emphasis on customer service, which helps build trust and reliability among clinicians. With a keen focus on expanding its capabilities and offering integrated testing solutions, Labcorp remains a formidable competitor in the Italian thyroid testing space. ### **Key Companies in the Italy Thyroid Test Market Include** - Thermo Fisher Scientific - **[Labcorp](https://www.ondemand.labcorp.com/lab-tests/thyroid-test?srsltid=AfmBOoqZqBaJBHp9sUnLSmkicjXrvUCNjtvm5isX6OMi8tv33s-elM-0)** - PerkinElmer - Medtronic - Abbott Laboratories - BioRad Laboratories - Eurofins Scientific - Fujirebio - Sonic Healthcare - Siemens Healthineers - Roche Diagnostics - Mayo Clinic Laboratories - Quest Diagnostics - BD - Ortho Clinical Diagnostics ## **Italy Thyroid Test Market Industry Developments** The Italy Thyroid Test Market has experienced significant movements recently. In September 2023, Thermo Fisher Scientific expanded its product offerings in the region, introducing advanced analytical tools that enhance thyroid function testing accuracy. Concurrently, Labcorp announced a strategic partnership with local healthcare providers in August 2023 to improve accessibility to thyroid testing services. Notably, in July 2023, Abbott Laboratories reported a 15% increase in thyroid test kit sales in Italy, driven by increased public awareness and screening efforts for thyroid disorders. Furthermore, in June 2023, PerkinElmer strengthened its market presence by acquiring a regional laboratory specializing in thyroid diagnostics. This acquisition is set to bolster its operational capacities in Italy. Throughout the last two to three years, there has been notable growth in market valuation, attributed to rising incidences of thyroid disorders and increasing investments in diagnostic technologies by companies like Siemens Healthineers and Roche Diagnostics. The Italian government's focus on early diagnosis and health campaigns has been pivotal in driving the demand for thyroid testing. Overall, these developments illustrate the dynamic nature of the Italy Thyroid Test Market as companies adapt and evolve in response to emerging health trends and consumer needs. ## **Italy Thyroid Test Market Segmentation Insights** ### **Thyroid Test Market Type Outlook** - TSH Tests - T4 Tests - T3 Tests - Other ### **Thyroid Test Market End User Outlook** - Hospital - Diagnostic Laboratories - Research Laboratories and Institutes ## Market Drivers ### Rising Geriatric Population The shift towards an aging population in Italy is significantly influencing the thyroid test market. As individuals age, the risk of developing thyroid disorders increases, making regular testing essential for early detection and management. Current statistics suggest that the geriatric population in Italy is projected to reach approximately 25% by 2030, which will likely lead to a corresponding rise in the demand for thyroid testing services. Healthcare providers are increasingly recognizing the need for targeted screening programs for older adults, thereby enhancing the market's growth potential. Furthermore, the integration of thyroid testing into routine health assessments for seniors is becoming more common, which may further bolster the thyroid test market in Italy as the population continues to age. ### Advancements in Diagnostic Technologies Technological innovations in diagnostic testing are significantly impacting the thyroid test market in Italy. The introduction of advanced testing methods, such as high-sensitivity assays and point-of-care testing, has improved the accuracy and speed of thyroid function assessments. These advancements not only enhance patient outcomes but also streamline the testing process, making it more efficient for healthcare providers. For instance, the use of automated systems in laboratories has reduced turnaround times for test results, which is crucial for timely diagnosis and treatment. As healthcare facilities increasingly adopt these technologies, the thyroid test market is expected to expand. Moreover, the integration of telemedicine and digital health solutions is likely to facilitate remote testing and monitoring, further driving the market's growth in Italy. ### Growing Interest in Preventive Healthcare The shift towards preventive healthcare practices is emerging as a key driver for the thyroid test market in Italy. Individuals are becoming more proactive about their health, seeking regular check-ups and screenings to identify potential health issues before they escalate. This trend is particularly evident in the context of thyroid health, where early detection can lead to more effective management of disorders. The increasing availability of health information through various channels, including social media and health apps, is empowering consumers to take charge of their health. Consequently, the thyroid test market is likely to benefit from this growing interest in preventive measures, as more individuals opt for thyroid testing as part of their routine health care. This proactive approach may lead to a sustained increase in testing rates and market growth. ### Increasing Prevalence of Thyroid Disorders The thyroid test market in Italy is experiencing growth due to the rising prevalence of thyroid disorders among the population. Recent studies indicate that approximately 5-10% of the Italian population may be affected by some form of thyroid dysfunction, with conditions such as hypothyroidism and hyperthyroidism being particularly common. This increasing incidence necessitates regular screening and testing, thereby driving demand for thyroid tests. Furthermore, as awareness of these disorders grows, more individuals are seeking medical advice and testing, contributing to the expansion of the thyroid test market. The healthcare system in Italy is adapting to this trend by integrating thyroid testing into routine health check-ups, which further supports market growth. As a result, the thyroid test market is likely to see a sustained increase in demand in the coming years. ### Government Initiatives for Health Promotion Government initiatives aimed at promoting public health are playing a pivotal role in the thyroid test market in Italy. Various health campaigns focused on educating the population about thyroid health and the importance of early detection are being implemented. These initiatives often include free or subsidized screening programs, which encourage individuals to undergo thyroid testing. As a result, there is a noticeable increase in the number of tests conducted, contributing to the overall growth of the thyroid test market. Additionally, the Italian government is collaborating with healthcare providers to ensure that testing is accessible to all segments of the population, including those in rural areas. This commitment to improving public health is likely to sustain the demand for thyroid tests in the foreseeable future. ## Future Outlook The [Thyroid Test Market](https://www.marketresearchfuture.com/reports/thyroid-test-market-8548) is projected to grow at a 5.29% CAGR from 2025 to 2035, driven by the increasing prevalence of thyroid disorders and advancements in diagnostic technologies. **New opportunities:** - Development of telehealth platforms for remote thyroid testing services. - Investment in AI-driven diagnostic tools for enhanced accuracy. - Expansion of point-of-care testing solutions in rural areas. By 2035, the thyroid test market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Type: TSH Tests (Largest) vs. T4 Tests (Fastest-Growing) The Italy thyroid test market showcases a competitive landscape among various test types, with TSH tests holding the largest market share due to their critical role in diagnosing thyroid disorders. These tests are widely accepted and frequently administered in clinical settings, making them the primary choice for healthcare providers. On the other hand, T4 tests are gaining traction, serving as an essential complement to TSH tests. Their growing adoption is indicative of increased awareness and the need for comprehensive thyroid assessments. In terms of growth dynamics, the T4 tests are classified as the fastest-growing segment driven by rising incidences of thyroid diseases and a growing emphasis on preventive healthcare. Additionally, advancements in testing technologies and the increasing availability of these tests in various healthcare facilities contribute to their popularity. As healthcare providers strive for precision in diagnostics, the market is likely to witness enhanced demand for both TSH and T4 tests over the coming years. TSH Tests (Dominant) vs. T4 Tests (Emerging) TSH tests are recognized as the dominant players in the Italy thyroid test market, largely due to their established efficacy in monitoring thyroid function. They provide critical insights into hypothyroidism and hyperthyroidism, thus being vital in patient management. The widespread familiarity of healthcare providers with TSH testing protocols further entrenches their position as the go-to choice for thyroid screening. Conversely, T4 tests are emerging as a necessary counterpart, gaining ground due to their specificity in evaluating thyroid hormone levels. This increase in demand is spurred by heightened public awareness and medical recommendations highlighting the importance of a comprehensive thyroid function evaluation, pushing T4 tests into a significant growth trajectory as healthcare systems evolve. ### By End-User: Hospital (Largest) vs. Diagnostic Laboratories (Fastest-Growing) In the Italy thyroid test market, hospitals hold the largest share, largely due to their extensive resources and patient access, offering a wide range of thyroid testing services. Diagnostic laboratories follow closely, driven by their specialized focus and the increasing prevalence of thyroid disorders among the population. The growth in this segment is primarily attributed to the rising awareness about thyroid health and the importance of early diagnosis. As healthcare providers, hospitals are expanding their testing capabilities, while diagnostic laboratories are leveraging advancements in technology and automation to enhance service delivery, capturing a growing patient base seeking efficient and accurate testing solutions. Hospital (Dominant) vs. Diagnostic Laboratories (Emerging) Hospitals are the dominant players in the Italy thyroid test market, providing comprehensive testing and treatment options within an integrated healthcare setting. Their capacity to manage larger patient volumes and offer diverse services drives their market position. Diagnostic laboratories, on the other hand, are emerging as key contributors by focusing on specialized thyroid testing services and innovative diagnostic techniques. They adapt quickly to market demands, emphasizing accuracy and speed in results, which appeals to both healthcare providers and patients. The competition between these two segments is intensifying, as each seeks to enhance their offerings and address the growing concerns surrounding thyroid health. ## Competitive Benchmarking The thyroid test market in Italy is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on digital transformation. Key players such as Abbott Laboratories (US), Roche Diagnostics (CH), and Siemens Healthineers (DE) are actively engaged in enhancing their product offerings and expanding their market presence. Abbott Laboratories (US) has positioned itself as a leader in the market by emphasizing the development of advanced diagnostic solutions, while Roche Diagnostics (CH) focuses on integrating cutting-edge technology into its testing processes. Siemens Healthineers (DE) appears to be leveraging its strong research capabilities to drive innovation in thyroid testing, thereby influencing the competitive dynamics of the market.The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing processes. The market structure is moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Abbott Laboratories (US) and Roche Diagnostics (CH) suggests a trend towards consolidation, as these firms seek to enhance their operational efficiencies and expand their geographical reach. In October Abbott Laboratories (US) announced the launch of a new thyroid function test that utilizes advanced biomarker technology, which is expected to improve diagnostic accuracy. This strategic move not only reinforces Abbott's commitment to innovation but also positions the company to capture a larger share of the growing demand for precise thyroid testing solutions. The introduction of this test may significantly enhance patient outcomes and streamline clinical workflows, thereby solidifying Abbott's competitive edge. In September Roche Diagnostics (CH) entered into a partnership with a leading Italian healthcare provider to enhance the accessibility of its thyroid testing services. This collaboration is likely to expand Roche's footprint in the Italian market, allowing for greater distribution of its innovative testing solutions. By aligning with local healthcare entities, Roche is not only increasing its market presence but also fostering trust and reliability among healthcare professionals and patients alike. In August Siemens Healthineers (DE) unveiled a new digital platform designed to integrate artificial intelligence into thyroid testing processes. This initiative aims to streamline laboratory operations and improve diagnostic efficiency. The strategic importance of this development lies in its potential to revolutionize the way thyroid tests are conducted, making them faster and more accurate. Siemens' focus on digitalization reflects a broader trend in the market towards leveraging technology to enhance service delivery. As of November the competitive trends in the thyroid test market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances among key players are shaping the current landscape, fostering innovation and enhancing service delivery. Looking ahead, it is anticipated that competitive differentiation will evolve, with a shift from price-based competition to a focus on technological advancements, innovation, and supply chain reliability. This transition underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive advantage in the dynamic market. ## Recent News & Developments The Italy Thyroid Test Market has experienced significant movements recently. In September 2023, Thermo Fisher Scientific expanded its product offerings in the region, introducing advanced analytical tools that enhance thyroid function testing accuracy. Concurrently, Labcorp announced a strategic partnership with local healthcare providers in August 2023 to improve accessibility to thyroid testing services. Notably, in July 2023, Abbott Laboratories reported a 15% increase in thyroid test kit sales in Italy, driven by increased public awareness and screening efforts for thyroid disorders. Furthermore, in June 2023, PerkinElmer strengthened its market presence by acquiring a regional laboratory specializing in thyroid diagnostics. This acquisition is set to bolster its operational capacities in Italy. Throughout the last two to three years, there has been notable growth in market valuation, attributed to rising incidences of thyroid disorders and increasing investments in diagnostic technologies by companies like Siemens Healthineers and Roche Diagnostics. The Italian government's focus on early diagnosis and health campaigns has been pivotal in driving the demand for thyroid testing. Overall, these developments illustrate the dynamic nature of the Italy Thyroid Test Market as companies adapt and evolve in response to emerging health trends and consumer needs. ## Report Scope | MARKET SIZE 2024 | 79.45(USD Million) | | --- | --- | | MARKET SIZE 2025 | 83.65(USD Million) | | MARKET SIZE 2035 | 140.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.29% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Abbott Laboratories (US), Roche Diagnostics (CH), Siemens Healthineers (DE), Thermo Fisher Scientific (US), PerkinElmer (US), Bio-Rad Laboratories (US), Ortho Clinical Diagnostics (US), Quest Diagnostics (US) | | Segments Covered | Type, End-User | | Key Market Opportunities | Integration of advanced diagnostic technologies enhances accuracy in the thyroid test market. | | Key Market Dynamics | Rising demand for thyroid testing driven by increased awareness and advancements in diagnostic technologies. | | Countries Covered | Italy | ## Frequently Asked Questions **Q: What was the market valuation of the thyroid test market in Italy in 2024?** A: The market valuation was $79.45 Million in 2024. **Q: What is the projected market valuation for the thyroid test market in Italy by 2035?** A: The projected valuation for 2035 is $140.0 Million. **Q: What is the expected CAGR for the thyroid test market in Italy during the forecast period 2025 - 2035?** A: The expected CAGR is 5.29% during the forecast period 2025 - 2035. **Q: Which companies are considered key players in the Italy thyroid test market?** A: Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, PerkinElmer, Bio-Rad Laboratories, Ortho Clinical Diagnostics, and Quest Diagnostics. **Q: What were the revenue figures for TSH tests in the Italy thyroid test market?** A: Revenue for TSH tests ranged from $30.0 Million to $54.0 Million. **Q: How do T4 tests perform in terms of revenue in the Italy thyroid test market?** A: T4 tests generated revenue between $25.0 Million and $45.0 Million. **Q: What is the revenue range for T3 tests in the Italy thyroid test market?** A: T3 tests accounted for revenue between $15.0 Million and $25.0 Million. **Q: What was the revenue contribution of diagnostic laboratories in the Italy thyroid test market?** A: Diagnostic laboratories contributed revenue ranging from $25.0 Million to $45.0 Million. **Q: What segment had the highest revenue in the Italy thyroid test market?** A: The hospital segment had the highest revenue, ranging from $30.0 Million to $54.0 Million. **Q: What is the revenue range for research laboratories and institutes in the Italy thyroid test market?** A: Research laboratories and institutes generated revenue between $24.45 Million and $41.0 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/italy-thyroid-test-market-51619*